AzTrials
AzTrials

Child MalnutritionNCT02257762

Efficacy of a Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement for Children Under Two in Cambodia

A study testing LNS, Corn-soy blend ++ (CSB++) and Sprinkles in people with Child Malnutrition, run by Institut de Recherche pour le Developpement, Cambodia at 1 site in Cambodia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this trial is to evaluate the efficacy of the LNS on children aged 6-17 months in preventing growth faltering and improving micronutrient status. The impact of product will be compared to Corn Soy Blend ++ (CSB++), Sprinkles, and to a control group consuming an unsupplemented diet, which is usually… Read more about this study

Who is it for?
Ages 6 to 12 monthsHealthy volunteers can take part
Conditions the study is for
Child Malnutrition
What is being tested?
LNS, Corn-soy blend ++ (CSB++) and Sprinkles
Could I receive a placebo?
No, everyone receives an active treatment
How many people
487 participants
Where
1 siteCambodia
Study dates
Feb 2016to Oct 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Children aged 6-12 months
  • Normally nourished or only moderately malnourished (MUAC>115mm, WHZ score>-3)
  • Have not received therapy for acute malnutrition within one month prior to presentation
  • Healthy (no ill-health in past two weeks)
  • Anaemia status - normal, mild or moderate
  • No known food intolerances
  • Informed signed consent of caregiver
  • Caregivers are healthy

Who cannot join

  • Children <6 months or >12mths
  • Severely malnourished (MUAC< 115mm, WHZ score<3, bipedal pitting oedema).
  • Have received therapy for acute malnutrition within one month prior to presentation
  • Any medical complications at the recruitment time or illness requiring referral or clinic visit in past 2 weeks
  • Severe anaemia (Hb<70g/l)
  • Known intolerances
  • No informed signed consent of caregiver

Trial locations and contacts

1 site in 1 country.

Cambodia1 site
  • IRD Cambodia

    Phnom Penh

Other trials in Cambodia

About this study

Official title: Efficacy of a Locally-Produced Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement (LNS) for Children Under Two Years in Cambodia

The purpose of this trial is to evaluate the efficacy of the LNS on children aged 6-17 months in preventing growth faltering and improving micronutrient status. The impact of product will be compared to Corn Soy Blend ++ (CSB++), Sprinkles, and to a control group consuming an unsupplemented diet, which is usually borbor at an early age, and thereafter, family foods.

Read the detailed description

BACKGROUND:

In Cambodia, progress in combatting malnutrition has stalled. In 2010, 40% of all children under five (and 49% of 4-5 year-olds) were stunted, 11% were wasted, and 28% were underweight, indicating, respectively, chronic and acute malnutrition, and a combination of the two. Stunting is partially attributed to poor complementary feeding, which remains inadequate for achieving growth outcomes and micronutrient status.

Malnutrition can be prevented with supplementary foods. These foods usually contain a source of protein and lipids such as powered milk, soy or peanuts, and multiple micronutrients. They can be prepared as a fortified blended product, such as Corn-Soy Blend++ (CSB++), that is mixed with water to make a porridge, or ready-to-use supplementary foods (RUSFs). The latter are usually lipid-based nutrient supplements (LNSs) which are often pastes such as the peanut-based Plumpy'Nut™. These energy-dense supplementary foods contain both macro and micronutrients and are used to prevent and treat moderate acute malnutrition by promoting improved linear growth, weight gain and micronutrient status among children. Until recently, treatment of moderate acute malnutrition has relied on fortified blended products. The new RUSFs are also proving effective, as they are higher energy and have a longer shelf life, and since they require no preparation, are convenient. Another common nutrition intervention is multiple micronutrient supplements such as Sprinkles. These are individually-packed powders that can be added to food. However, micronutrients are more likely to achieve growth outcomes when they are combined with energy, for example, in lipid-based nutrient supplements and there is no evidence that micronutrient powders alone contribute to growth.

Until June 2014, the United Nations World Food Program (WFP) used CSB++ (now called Supercereal Plus) to treat and prevent moderate acute malnutrition in Cambodia. Sprinkles are also being distributed, though not widely, to prevent micronutrient deficiencies. These products that have been recently or are currently used are relatively expensive to procure and ship to Cambodia and in the case of Sprinkles, are not as effective as foods that contain macronutrients. Moreover, CSB++ was not very well accepted in practice, and WFP has phased it out. Therefore, UNICEF and the Cambodian Ministry of Health are looking for a locally-produced product containing macro and micronutrients to prevent growth faltering and improve micronutrient status in Cambodian children.

TRIAL DESIGN AND METHODOLOGY:

Therefore, this trial will evaluate the efficacy of the LNS on children aged 6-17 months in preventing growth faltering and improving micronutrient statu. The impact of product will be compared to CSB++, Sprinkles, and to a control group.

The trial is a prospective, cluster randomised, non-blinded controlled trial among infants 6-17 months of age. The trial aims to establish the superiority of the novel LNS, using CSB++ and Sprinkles as active comparators and the unimproved diet as a control. The allocation ratio is 1:1. The study will take place over 8 months.

The study will be conducted in 28 sites in peri-urban Phnom Penh. Infants aged 6-12 months will be recruited. Upon consent and enrolment, baseline data will be collected from the participants. This will include demographics, morbidity, anthropometry (weight, height, mid-upper arm circumference, skinfolds), haematological and stool samples, dietary data (breastfeeding, food frequency and dietary diversity). Data will be collected monthly, and haematological samples will be collected again at endline.

Participants will then be provided with a one month supply of the food to which their site has been allocated. Staff will explain how to prepare the food, how often it should be consumed, and who should consume it (i.e. subjects). Participants will be provided with food on a monthly basis. They will continue to consume the food over a six-month period, at which time endline data, including haematological samples, will be collected.

Being tested
LNS, Corn-soy blend ++ (CSB++), Sprinkles
Keywords
Ready-to-use supplementary food (RUSF), Lipid-based nutrient supplement (LNS), Multiple micronutrients (MMN), Complementary feeding, Home fortification, Efficacy/impact, Infant and young child feeding (IYCF), Cambodia, Cluster randomised controlled trial
Medical subject headings
Child Nutrition Disorders, Tooth, Impacted

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LNSDietary supplement

    Compact, paste-filled wafer snack containing fish, rice, soy, mungbeans, oil, sugar and multiple micronutrients

  • Corn-soy blend ++ (CSB++)Dietary supplement

    Also called Supercereal Plus

    Blended flour containing soy, corn, milk powder, oil, sugar and multiple micronutrients.

  • SprinklesDietary supplement

    Multiple micronutrient powder packaged in sachet.

Study groups in NCT02257762
Study groupRoleWhat they receive
Lipid-based nutrient supplement (LNS)ExperimentalLNS added to borbor, eaten over 6 months, age 6-12 months to age 11-17 months
Receives: Dietary Supplement: LNS
Corn-soy blend ++ (CSB++)Active comparatorCSB++ porridge, eaten over 6 months, age 6-12 months to age 11-17 months
Receives: Dietary Supplement: Corn-soy blend ++ (CSB++)
SprinklesActive comparatorSprinkles added to borbor, eaten over 6 months, age 6-12 months to age 11-17 months
Receives: Dietary Supplement: Sprinkles
ControlNo interventionPlain borbor and thereafter family foods, eaten over 6 months, age 6-12 months to age 11-17 months

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nutritional status

    Weight-for-height (WHZ), length/height-for-age (L/HAZ), and weight-for-age (WAZ) calculated through monthly weight and height measurements

    Measured: 6 months

Secondary outcomes (2)
  1. Body composition

    Triceps, biceps and/or subscapular skinfolds

    Measured: 6 months

  2. Iron status

    Analysis of haemoglobin (g/l), ferritin (µg/l), tranferrin receptor (mg/l), C reactive protein (mg/l), and alpha-1-acid glycoprotein (mg/l)

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2014 (estimated)
  2. Study startFeb 2016
  3. Primary completionOct 2016 (estimated)
  4. Study completionOct 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
487 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02257762
Sponsor's protocol ID
LNS-CAMB-INFANTS-EFF
Status last verified
Sep 2016
First submitted
2 Oct 2014
Last updated
15 Sep 2016
Results posted
No
Data monitoring committee
No

Publications

  • Borg B, Sok D, Mihrshahi S, Griffin M, Chamnan C, Berger J, Laillou A, Roos N, Wieringa FT. Effectiveness of a locally produced ready-to-use supplementary food in preventing growth faltering for children under 2 years in Cambodia: a cluster randomised controlled trial. Matern Child Nutr. 2020 Jan;16(1):e12896. doi: 10.1111/mcn.12896.

    PubMed 31885221
  • Borg B, Mihrshahi S, Griffin M, Sok D, Chhoun C, Laillou A, Berger J, Wieringa FT. Randomised controlled trial to test the effectiveness of a locally-produced ready-to-use supplementary food (RUSF) in preventing growth faltering and improving micronutrient status for children under two years in Cambodia: a study protocol. Nutr J. 2018 Mar 16;17(1):39. doi: 10.1186/s12937-018-0346-x.

    PubMed 29548287

Questions about this trial

What is this clinical trial studying?

A study testing LNS, Corn-soy blend ++ (CSB++) and Sprinkles in people with Child Malnutrition, run by Institut de Recherche pour le Developpement, Cambodia at 1 site in Cambodia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Cambodia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nutritional status (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02257762, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in